Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Targets for indole-3-carbinol in cancer prevention.

Kim YS, Milner JA.

J Nutr Biochem. 2005 Feb;16(2):65-73. Review.

PMID:
15681163
4.

Estrogen receptor alpha as a target for indole-3-carbinol.

Wang TT, Milner MJ, Milner JA, Kim YS.

J Nutr Biochem. 2006 Oct;17(10):659-64. Epub 2005 Nov 28.

PMID:
16488130
5.

Indole-3-carbinol and prostate cancer.

Sarkar FH, Li Y.

J Nutr. 2004 Dec;134(12 Suppl):3493S-3498S. Review.

6.

Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol.

Ashok BT, Chen Y, Liu X, Bradlow HL, Mittelman A, Tiwari RK.

Nutr Cancer. 2001;41(1-2):180-7.

PMID:
12094623
7.
8.

Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.

Rahman KM, Sarkar FH, Banerjee S, Wang Z, Liao DJ, Hong X, Sarkar NH.

Mol Cancer Ther. 2006 Nov;5(11):2747-56.

9.
10.

A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals.

Minich DM, Bland JS.

Nutr Rev. 2007 Jun;65(6 Pt 1):259-67. Review.

PMID:
17605302
11.

3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease.

Tadi K, Chang Y, Ashok BT, Chen Y, Moscatello A, Schaefer SD, Schantz SP, Policastro AJ, Geliebter J, Tiwari RK.

Biochem Biophys Res Commun. 2005 Nov 25;337(3):1019-25. Epub 2005 Oct 3.

PMID:
16219298
12.

Indole-3-carbinol induces tumor cell death: function follows form.

Megna BW, Carney PR, Nukaya M, Geiger P, Kennedy GD.

J Surg Res. 2016 Jul;204(1):47-54. doi: 10.1016/j.jss.2016.04.021. Epub 2016 Apr 22. Review.

13.

Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer.

Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK.

Prostate. 2006 Apr 1;66(5):453-62.

PMID:
16353249
14.

Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailability.

Song JM, Kirtane AR, Upadhyaya P, Qian X, Balbo S, Teferi F, Panyam J, Kassie F.

Int J Pharm. 2014 Dec 30;477(1-2):96-101. doi: 10.1016/j.ijpharm.2014.10.018. Epub 2014 Oct 11.

15.

Molecular targets and anticancer potential of indole-3-carbinol and its derivatives.

Aggarwal BB, Ichikawa H.

Cell Cycle. 2005 Sep;4(9):1201-15. Epub 2005 Sep 6. Review.

PMID:
16082211
16.
17.

Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats.

Parkin DR, Lu Y, Bliss RL, Malejka-Giganti D.

Food Chem Toxicol. 2008 Jul;46(7):2451-8. doi: 10.1016/j.fct.2008.03.029. Epub 2008 Apr 6.

PMID:
18486294
18.
19.

Quantitative determination of 3,3'-diindolylmethane in urine of individuals receiving indole-3-carbinol.

Sepkovic DW, Bradlow HL, Bell M.

Nutr Cancer. 2001;41(1-2):57-63.

PMID:
12094629
20.

Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells.

Marconett CN, Sundar SN, Tseng M, Tin AS, Tran KQ, Mahuron KM, Bjeldanes LF, Firestone GL.

Carcinogenesis. 2011 Sep;32(9):1315-23. doi: 10.1093/carcin/bgr116. Epub 2011 Jun 21.

Supplemental Content

Support Center